China Medical GatewayLoading your healthcare gateway…

Knowledge Center

China's innovative therapies lead new cancer battle

China approved satri-cel as the world’s first CAR-T product for a solid tumor, extending a treatment once limited commercially to blood cancers.

China Daily

China Completes First Demo Unit of Next-gen Heavy-ion Cancer Therapy Accelerator

China completed a compact next-generation heavy-ion accelerator in Huizhou, with clinical trials expected by the end of 2026 and potential for wider cancer treatment.

Institute of Modern Physics, CAS

Chinese Surgical Robots Surpass Da Vinci in Domestic Market Share, Expanding into Global Remote Surgery

MicroPort MedBot’s Toumai overtook Da Vinci in China’s laparoscopic surgical-robot market during January–May 2026, marking a milestone for domestic systems.

Pandaily

In China, A.I. Is Finding Deadly Tumors That Doctors Might Miss

PANDA reviewed more than 180,000 routine CT scans at a Ningbo hospital, helping detect about two dozen pancreatic cancers, including 14 early-stage cases.

The New York Times

China’s domestic BCI systems prove effectiveness, potential to bridge biological and artificial intelligence

Tsinghua’s wireless NEO implant enabled two paralyzed trial participants to control devices with their thoughts, with one recovering some grasping function.

Global Times

57-year-old patient with end-stage heart failure receives Rocket Heart

China’s HeartCon LVAD supported a 57-year-old patient with end-stage heart failure, while a 75-gram next-generation version advanced through clinical trials.

China Daily

Chinese trial backs base-editing drug for thalassaemia

All five patients in a Chinese trial stopped transfusions after one infusion of CS-101, a base-editing therapy for transfusion-dependent beta-thalassaemia.

pharmaphorum

Pig-to-human kidney transplant in China offers hope to millions in organ crisis

A gene-edited pig kidney produced urine and maintained early function after transplantation into a 69-year-old woman with end-stage kidney disease in China.

CGTN

World-First Stem Cell Treatment Reverses Diabetes for a Patient in China, Study Suggests

Chinese researchers reprogrammed a woman's own cells into insulin-producing islets; more than a year after transplantation, she remained free of insulin injections.

Smithsonian Magazine

New kit for lung cancer early detection approved for market in China

A Chinese blood test analyzing 13 tumor-autoantibody biomarkers has received Class III registration, offering a new way to flag malignant lung nodules earlier.

CGTN

3D-printed medical devices gain ground

China's 3D-printed medical device sector is expanding, highlighted by NMPA approval of Wedo-Bio's porous titanium cage for degenerative spinal diseases.

China Daily

Next-gen multimodal large model cuts cost of lung cancer genetic testing

DeepGEM 2.0 uses pathology images to pre-screen lung cancer gene targets in about one minute, with validation planned across 50 medical institutions.

China Daily

Ancient medicine pairs up with AI

China is pairing AI, stricter standards and smart manufacturing with TCM to improve scientific validation, production consistency and global competitiveness.

China Daily

VenusA-Plus four-year clinical data released: Comparable or superior to international counterparts

Venus Medtech reports four-year follow-up data for VenusA-Plus, China's first retrievable TAVR device, showing stable valve performance and no new cardiac deaths.

Venus Medtech

Chinese team offers remote treatment

A Chinese team in Rome used a domestic robot and 5G+ link to remove a patient's prostate cancer in Beijing, more than 8,000 kilometers away.

China Daily

Deep brain stimulation successful for one in two patients with treatment-resistant severe depression and anxiety

In a 26-patient open-label trial at Shanghai's Ruijin Hospital, DBS improved depression and anxiety in half of participants, while theta activity helped predict response.

University of Cambridge

Country's first robotic heart transplant a success

Chinese doctors completed the country’s first robotic heart transplant without splitting the patient’s breastbone. The Xi’an procedure was the third of its kind worldwide.

China Daily

Chinese hospitals accelerate AI-powered health care transformation

Chinese hospitals are embedding large language models into triage, imaging and medical documentation, moving AI from laboratory trials into everyday clinical workflows.

Global Times

From rarity to recognition: A brighter future for rare disease patients

China’s rare-disease collaboration network now links 419 hospitals nationwide, helping shorten average diagnosis time from more than four years to four weeks.

CGTN

A novel framework integrating AI model and enzymological experiments promotes identification of SARS-CoV-2 3CL protease inhibitors and activity-based probe

Chinese researchers developed AIMEE, an iterative AI-and-experiment framework that identified six novel SARS-CoV-2 3CL protease inhibitors, four with IC50 values below 3 μM.

Briefings in Bioinformatics

Genetic deconvolution of fetal and maternal cell-free DNA in maternal plasma enables next-generation non-invasive prenatal screening

A Chinese team’s COATE-seq method separates fetal and maternal cfDNA, enabling broader non-invasive screening for chromosomal and monogenic disorders.

Cell Discovery

Chinese scientists develop world’s first bionic auditory neural interface, enabling artificial auditory nerve to ‘understand’ sounds

Nankai University researchers say their bionic auditory neural interface could help cochlear implant technology move beyond hearing sounds toward understanding them.

Global Times

Pfizer signs licensing deal worth about $6 billion with China's 3SBio for cancer drug

Pfizer signed a licensing agreement worth about $6 billion with China’s 3SBio for SSGJ-707, a cancer drug candidate in clinical trials.

Reuters (via The Economic Times)

Augmented Reality Navigation for Stereoscopic Laparoscopic Anatomical Hepatectomy of Primary Liver Cancer: Preliminary Experience

A Chinese clinical study found that laparoscopic augmented-reality navigation helped identify liver anatomy and reduced bleeding and hospital stays in liver-cancer surgery.

Frontiers in Oncology

Return to Home